Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

Patients with acanthosis nigricans often have insulin resistance and signs of increased male hormones, but treatment targeting these male hormones is generally ineffective.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Accurate clinical, histological, and genetic methods are key for understanding and treating hair disorders.

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

Good preoperative assessment is crucial for safe and effective eyelid and brow cosmetic surgery.

Metformin should be used for PCOS mainly in those with glucose intolerance, and has limited benefits for infertility or hirsutism.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

The document concludes that accurate diagnosis and treatment of scalp itch require differentiating between various conditions using a proposed five-step evaluation process.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Different markers are found in stem cells of the scalp's hair follicle bulge and the surrounding skin.

Obesity worsens Polycystic Ovary Syndrome symptoms, and weight loss is a key treatment.

Behavior therapy and medications, especially clomipramine, can help reduce hair pulling in people with trichotillomania.

Disrupting Notch signaling in blood vessels increases scarring during wound healing in mice.

High levels of TNF-α may contribute to obesity and insulin resistance in PCOS, but not due to the C850T genetic variation.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Deoxycholic acid is effective for reducing chin fat but can cause side effects and serious complications, so careful patient evaluation is needed.

Mesotherapy might help reduce fat in specific areas for those close to their ideal weight, but more research and care are needed to ensure safety.

Most pregnant women experience skin changes like darkening and itching, while serious skin conditions are rare but need early treatment.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.